Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEST.L Share News (DEST)

  • There is currently no data for DEST

DEST.L News

Destiny Pharma Biofilm Project With Southampton Uni Secures Funding
1 Nov 2018

Destiny Pharma Biofilm Project With Southampton Uni Secures Funding

LONDON (Alliance News) - Destiny Pharma PLC said Thursday it had been jointly granted funding with the University of Southampton to examine the use of...

Destiny Pharma Hires Creabilis's Shaun Claydon As New Finance Head
25 Oct 2018

Destiny Pharma Hires Creabilis's Shaun Claydon As New Finance Head

LONDON (Alliance News) - Destiny Pharma PLC said on Thursday it has appointed Shaun Claydon as its new finance chief after the departure of Chief Fina...

Destiny Pharma helps with new bioindustry association videos
19 Oct 2018

Destiny Pharma helps with new bioindustry association videos

(Sharecast News) - Clinical-stage biotechnology company Destiny Pharma noted the launch of a series of videos and explainer documents from the UK BioI...

Destiny Pharma Loss More Than Doubles On Administrative Expenses
26 Sep 2018

Destiny Pharma Loss More Than Doubles On Administrative Expenses

LONDON (Alliance News) - Destiny Pharma PLC on Wednesday reported a substantial widening of its loss in the first half of the year due to administrati...

Destiny Pharma Chairman Nigel Rudd To Step Down In December
6 Sep 2018

Destiny Pharma Chairman Nigel Rudd To Step Down In December

LONDON (Alliance News) - Destiny Pharma PLC said Thursday that Chairman Nigel Rudd stepped down from the company in December after eight years.Non-Exe...

Chairman of Destiny calling time after 15 years with pharma firm
6 Sep 2018

Chairman of Destiny calling time after 15 years with pharma firm

(Sharecast News) - Clinical stage biotechnology firm Destiny Pharma revealed on Thursday that long-time chairman Nigel Rudd was stepping down from the...

Destiny Pharma Receives Positive Results From Skin Irritation Study
26 Jul 2018

Destiny Pharma Receives Positive Results From Skin Irritation Study

LONDON (Alliance News) - Destiny Pharma PLC said Thursday that it received positive data from the Phase I of its XF-73 skin irritation study.The clini...

Destiny Pharma Appoints SEHTA Chairman Nick Rodgers As Non-Executive
21 Jun 2018

Destiny Pharma Appoints SEHTA Chairman Nick Rodgers As Non-Executive

LONDON (Alliance News) - Anti-microbial resistance-focused biotechnology developer Destiny Pharma PLC said Thursday it has appointed Nick Rodgers as a...